A pharmacokinetics study published in the Journal of Pharmaceutical and Biomedical Analysis provides a closer look at how potent phenolic compounds in a standardized pomegranate extract are metabolized by gut microbiota to confer health benefits.
Regulation of CBD, or lack thereof, is one challenge that the CBD industry faces. Another is bioavailability, which is impacted by quality, delivery method, and pharmacokinetics.